Want to see TSE:PHRX full AI Analyst Report?
Pharmadrug (PHRX) Financial Statements
Pharmadrug Financial Overview
Pharmadrug's market cap is currently $671.07K. The company's EPS TTM is $-0.01; its P/E ratio is -0.93; Pharmadrug is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 7.01K |
| Gross Profit | $ -50.24K | $ -50.24K | $ -26.22K | $ -2.26K | $ -2.15K |
| Operating Income | $ -225.93K | $ -668.66K | $ -1.33M | $ -2.43M | $ -2.80M |
| EBITDA | $ -71.98K | $ -549.04K | $ -1.33M | $ -2.34M | $ -4.21M |
| Net Income | $ -383.38K | $ -793.27K | $ -13.20M | $ -8.88M | $ -5.87M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 23.24K | $ 75.04K | $ 423.06K | $ 329.24K | $ 1.30M |
| Total Assets | $ 551.66K | $ 711.80K | $ 1.20M | $ 12.11M | $ 19.52M |
| Total Debt | $ 1.52M | $ 1.35M | $ 1.77M | $ 1.42M | $ 866.37K |
| Net Debt | $ 1.50M | $ 1.27M | $ 1.36M | $ 1.41M | $ -91.62K |
| Total Liabilities | $ 2.20M | $ 1.96M | $ 2.66M | $ 3.28M | $ 2.66M |
| Stockholders' Equity | $ -1.76M | $ -1.40M | $ -1.70M | $ 8.84M | $ 16.87M |
| Cash Flow | |||||
| Free Cash Flow | $ -87.51K | $ -768.60K | $ -671.88K | $ -2.26M | $ -4.17M |
| Operating Cash Flow | $ -87.51K | $ -756.62K | $ -671.88K | $ -2.26M | $ -4.13M |
| Investing Cash Flow | $ 0.00 | $ -11.98K | $ 995.04K | $ 77.58K | $ 1.48M |
| Financing Cash Flow | $ 0.00 | $ 321.56K | $ 225.51K | $ 843.25K | $ 776.97K |
Currency in CAD